Xcorporeal (Xcorporeal) Inventory-to-Revenue : 0.00 (As of Sep. 2009)

View and export this data going back to . Start your Free Trial

What is Xcorporeal Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Xcorporeal's Average Total Inventories for the quarter that ended in Sep. 2009 was $0.00 Mil. Xcorporeal's Revenue for the three months ended in Sep. 2009 was $0.00 Mil.

Xcorporeal's Inventory-to-Revenue for the quarter that ended in Sep. 2009 stayed the same from Jun. 2009 (0.00) to Jun. 2009 (0.00)

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Xcorporeal Inventory-to-Revenue Historical Data

The historical data trend for Xcorporeal's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xcorporeal Inventory-to-Revenue Chart

Xcorporeal Annual Data

Trend

Feb99

Feb00

Dec01

Dec02

Dec03

Dec04

Dec05

Dec06

Dec07

Dec08

Inventory-to-Revenue

Get a 7-Day Free Trial

Xcorporeal Quarterly Data
	Dec04	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09
Inventory-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Xcorporeal's Inventory-to-Revenue

For the Medical Devices subindustry, Xcorporeal's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Xcorporeal's Inventory-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Xcorporeal's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Xcorporeal's Inventory-to-Revenue falls into.

Xcorporeal Inventory-to-Revenue Calculation

Xcorporeal's Inventory-to-Revenue for the fiscal year that ended in Dec. 2008 is calculated as

	Inventory-to-Revenue (A: Dec. 2008 )
=	Average Total Inventories					/	Revenue
=	( (Total Inventories (A: Dec. 2007 )	+	Total Inventories (A: Dec. 2008 ))	/	count )	/	Revenue (A: Dec. 2008 )
=	( (0	+	0)	/	1 )	/	0
=	0					/	0
=	N/A

Xcorporeal's Inventory-to-Revenue for the quarter that ended in Sep. 2009 is calculated as

	Inventory-to-Revenue (Q: Sep. 2009 )
=	Average Total Inventories					/	Revenue
=	( (Total Inventories (Q: Jun. 2009 )	+	Total Inventories (Q: Sep. 2009 ))	/	count )	/	Revenue (Q: Sep. 2009 )
=	( (0	+	0)	/	1 )	/	0
=	0					/	0
=

Xcorporeal (GREY:XCRP) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Xcorporeal's Days Inventory for the three months ended in Sep. 2009 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Sep. 2009 )	/	Cost of Goods Sold (Q: Sep. 2009 )	*	Days in Period
	=	0	/	0	*	365 / 4
	=

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Xcorporeal's Inventory Turnover for the quarter that ended in Sep. 2009 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Sep. 2009 )	/	Average Total Inventories (Q: Sep. 2009 )
	=	0	/	0
	=

Xcorporeal Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of Xcorporeal's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Xcorporeal (Xcorporeal) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Xcorporeal Inc (GREY:XCRP) » Definitions » Inventory-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

80 Empire Drive, Lake Forest, CA, USA, 92630

Website

Xcorporeal Inc is a medical device company, developing an innovative extra-corporeal platform technology to be used in devices to replace the function of various human organs.

Executives

Kelly J. Mccrann	director, officer: Chairman and CEO	11150 SANTA MONICA BLVD #1500, LOS ANGELES CA 90025
Daniel S Goldberger	officer: Chief Executive Officer	24 CARPENTER ROAD, CHESTER NY 10918
Marc G Cummins	director	C/O PRIME LOGIC CAPITAL, LLC, 135 EAST 57TH STREET, 11TH FLOOR, NEW YORK NY 10022
Prime Logic Capital, Llc	10 percent owner	135 EAST 57TH STREET, 11TH FLOOR, NEW YORK NY 10022
Robert Weinstein	officer: Chief Financial Officer	3960 HOWARD HUGHES PARKWAY, SUITE 500, LAS VEGAS NV 89169
Terren S Peizer	director, 10 percent owner, officer: Executive Chairman	11111 SANTA MONICABLVD STE.500, LOS ANGELES CA 90025
Jay Wolf	director	981 LINDA FLORA DRIVE, LOS ANGELES, CA 90049
Herve De Kergrohen	director	22 CHEMIN DU NANTET, COLLONGE-BELLERIVE V8 CH1245
Nicholas Sheridan Lewin	director	3 WEST 57TH ST., 8TH FLOOR, NEW YORK NY 10019
Lawrence Lacerte	10 percent owner	C/O TERAGLOBAL COMMUNICATIONS CORP, 9171 TOWNE CENTRE DRIVE SUITE 600, SAN DIEGO CA 92122